While 340B ESP provides an avenue to assist Covered Entities in regaining access to 340B medications to continue supporting underserved patients, the complexity and timeliness issues inherent in 340B ESP have created many new challenges. Managing compliance while also optimizing program performance and ensuring continued revenue success are essential to a robust 340B Program, even more as a result of the hits that CEs have taken as a result of manufacturers refusal to provide 340B prices for contract pharmacy over the past two years. Visante’s 340B consulting practice has successfully supported dozens of clients with various aspects of 340B ESP submission and revenue recovery and has developed a unique approach to best support our clients’ needs. Kristin Fox-Smith, Managing Director, and Angela De Ianni, Senior director, will present 5 practice tips to navigate 340B ESP and optimize your program performance:

Topics to cover:

• How to streamline data submission
• How to establish audit practices among TPA’s and wholesalers
• How to track pricing restoration
• Reporting of price restoration
• Ongoing success related to 340B ESP

Read on thinc360.com

Continue reading at thinc360.com

Pharmacy

Facebook Share

Twitter Share

Linkedin Share

Email Share